Dr Simona Glasberg
Head of the Neuroendocrine Tumor Unit & Senior Lecturer in Endocrinology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
A specialist in endocrinology and internal medicine, Dr. Glasberg completed a fellowship in Neuroendocrinology at St. Bartholomew's Hospital & William Harvey Research Institute, London, UK, exploring the mechanisms by which somatostatin analogues regulate the growth of NETs, and their interaction with mTOR inhibitors. Established as one of the foremost experts in the diagnosis and management of NETs in Israel, Dr. Glasberg is actively involved in both, the care of patients with NETs, as well as in the research in the field. Dr. Glasberg is a member of the Advisory Board of the European Neuroendocrine Tumor Society (ENETS). She has published extensively in peer-reviewed journals, and presented at national and international conferences on the topic of NETs. Dr. Glasberg is the recipient of the prestigious 2017 Lindner Prize of the Israel Endocrine Society, in recognition for her scientific achievements and contribution in the field of NETs.